The association of circulating leptin level with peripheral DNA damage in hemodialysis subjects

Clinical Biochemistry

Volumn 39, Issue 9, 2006, Pages 918-922

  Horoz, Mehmet ^a   Bolukbas, Filiz F ^a   Bolukbas, Cengiz ^a   Aslan, Mehmet ^a   Koylu, Ahmet O ^a   Gunaydin, Necla ^a   Selek, Sahbettin ^a   Kocyigit, Abdurrahim ^a  

^a HARRAN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Chronic renal failure; Comet assay; DNA damage; Hemodialysis; Leptin; Lymphocyte

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA; LEPTIN; UREA;

ADULT; APOPTOSIS; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; COMET ASSAY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA DAMAGE; FEMALE; HEMODIALYSIS; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNORADIOMETRIC ASSAY; INTERSTITIAL NEPHRITIS; MALE; NEPHROSCLEROSIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SERUM; SEX DIFFERENCE; SKINFOLD THICKNESS; UREA NITROGEN BLOOD LEVEL;

ADULT; COMET ASSAY; CROSS-SECTIONAL STUDIES; DNA DAMAGE; DRUG ADMINISTRATION ROUTES; FEMALE; HUMANS; KIDNEY DISEASES; LEPTIN; MALE; RENAL DIALYSIS;

EID: 33748431939     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.05.012     Document Type: Article

References (37)

1. Friedman J.M. Leptin, leptin receptors and the control of body weight. Eur J Med Res 2 (1997) 7-13
2. Klein S., Coppack S.W., Mohamed-Ali V., et al. Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 45 (1996) 984-987
3. Merabet E., Dagogo-Jack S., Coyne D.W., et al. Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab 82 (1997) 847-850
4. Heimburger O., Lonnqvist F., Danielsson A., et al. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 15 (1997) 1423-1430
5. Loft S., and Poulsen H.E. Markers of oxidative damage to DNA: antioxidants and molecular damage. Methods Enzymol 300 (1999) 166-184
6. Ames B.N., Shigenaga M.K., and Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 90 (1993) 7915-7922
7. Zevin D., Malachi T., Gafter U., et al. Impaired DNA repair in patients with end-stage renal disease and its improvement with hemodialysis. Miner Electrolyte Metab 17 (1991) 303-306
8. Cengiz K., Block A.M., Hossfeld D.K., et al. Sister chromatid exchange and chromosome abnormalities in uremic patients. Cancer Genet Cytogenet 36 (1988) 55-67
9. Maisonneuve P., Agodoa L., Gellert R., et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354 (1999) 93-99
10. Herzog C.A., Ma J.Z., and Collins A.J. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 39 (1998) 799-805
11. Qian H., Azain M.J., Compton M.M., et al. Brain administration of leptin causes deletion of adipocytes by apoptosis. Endocrinology 139 (1998) 791-794
12. Utsumi H., Iwakiri R., Wu B., et al. Intracerebroventricular administration of leptin-induced apoptosis in the rat small intestinal mucosa. Exp Biol Med (Maywood) 228 (2003) 1239-1244
13. Fedorcsak P., and Storeng R. Effects of leptin and leukemia inhibitory factor on preimplantation development and STAT3 signaling of mouse embryos in vitro. Biol Reprod 69 (2003) 1531-1538
14. Jackson A.S., Pollock M.L., and Ward A. Generalized equations for predicting body density of women. Med Sci Sports Exerc 12 (1980) 175-181
15. Singh N.P., McCoy M.T., Tice R.R., et al. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 17 (1988) 184-191
16. Kan E., Undeger U., Bali M., et al. Assessment of DNA strand breakage by the alkaline COMET assay in dialysis patients and the role of Vitamin E supplementation. Mutat Res 520 (2002) 151-159
17. Inagi R., and Miyata T. Oxidative protein damage with carbohydrates and lipids in uremia: 'carbonyl stress'. Blood Purif 17 (1999) 95-98
18. Tepel M., Echelmeyer M., Orie N.N., et al. Increased intracellular reactive oxygen species in patients with end-stage renal failure: effect of hemodialysis. Kidney Int 58 (2000) 867-872
19. Matas A.J., Simmons R.L., Kjellstrand C.M., et al. Increased incidence of malignancy during chronic renal failure. Lancet 1 (1975) 883-886
20. Stewart J.H., Buccianti G., Agodoa L., et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14 (2003) 197-207
21. Kassie F., Parzefall W., and Knasmuller S. Single cell gel electrophoresis assay: a new technique for human biomonitoring studies. Mutat Res 463 (2000) 13-31
22. McKelvey-Martin V.J., Green M.H., Schmezer P., Pool-Zobel B.L., De Meo M.P., and Collins A. The single cell gel electrophoresis assay (comet assay): a European review. Mutat Res 288 (1993) 47-63
23. Fairbairn D.W., Olive P.L., and O'Neill K.L. The comet assay: a comprehensive review. Mutat Res 339 (1995) 37-59
24. Stenvinkel P., Heimburger O., and Lonnqvist F. Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. Nephrol Dial Transplant 12 (1997) 1321-1325
25. Mehrotra R., and Kopple J.D. Nutritional management of maintenance dialysis patients: why aren't we doing better?. Annu Rev Nutr 21 (2001) 343-379
26. Sharma K., Considine R.V., Michael B., et al. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 51 (1997) 1980-1985
27. Stamatiadis D.N., Chan J.L., Cogswell R., et al. Elevated leptin fragments in renal failure correlate with BMI and haematopoiesis and are normalized by haemodialysis. Clin Endocrinol (Oxf) 60 (2004) 434-441
28. Ottonello L., Gnerre P., Bertolotto M., et al. Leptin as a uremic toxin interferes with neutrophil chemotaxis. J Am Soc Nephrol 15 (2004) 2366-2372
29. Zoccali C., Mallamaci F., and Tripepi G. Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease. Nephrol Dial Transplant 19 (2004) 67-72
30. Menon V., Wang X., Greene T., et al. Factors associated with serum leptin in patients with chronic kidney disease. Clin Nephrol 61 (2004) 163-169
31. Stopper H., Schupp N., Klassen A., Sebekova K., and Heidland A. Genomic damage in chronic renal failure-Potential therapeutic interventions. J Renal Nutr 15 (2005) 81-86
32. Stopper H., Boullay F., Heidland A., Vienken J., and Bahner U. Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients. Am J Kidney Dis 38 (2001) 296-301
33. Witko-Sarsat V., Friedlander M., Capeillere-Blandin C., et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49 (1996) 1304-1313
34. Nakanishi S., Yamane K., Kamei N., et al. A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane. Metabolism 54 (2005) 194-199
35. Kutlu S., Canpolat S., Aydin M., et al. Exogenous leptin increases lipid peroxidation in the mouse brain. Tohoku J Exp Med 206 (2005) 223-233
36. Kalousova M., Sulkova S., Zima T., et al. Advanced glycation end products in hemodialyzed patients with diabetes mellitus correlate with leptin and leptin/body fat ratio. Ren Fail 25 (2003) 277-286
37. Efferth T., Fabry U., and Osieka R. Leptin contributes to the protection of human leukemic cells from cisplatinum cytoxicity. Anticancer Res 20 (2000) 2541-2546